歡迎光臨源葉生物,登錄 | 注冊 |
當(dāng)前位置: 首頁 > 小分子抑制劑 > GPCR/GProtein > MK-1064

瀏覽歷史

S82344

MK-1064

MedMol 99%
  • 英文名:
  • MK-1064
  • 別名:
  • 5’’-chloro-N-[(5,6-dimethoxypyridin-2-yl)methyl]-2,2’:5’,3’’-terpyridine-3’-carboxamide; 5''-chloro-N-[(5,6-dimethoxypyridin-2-yl)methyl]-2,2':5',3''-terpyridine-3'-carboxamide; 5''-chloro-N-((5,6-dim
  • CAS號(hào):
  • 1207253-08-4
  • 分子式:
  • C24H20ClN5O3
  • 分子量:
  • 461.9003
  • 核磁/質(zhì)譜:
品牌貨號(hào)產(chǎn)品規(guī)格價(jià)格(RMB) 庫存(上海) 北京 武漢 南京 數(shù)量計(jì)量單位 加入購物車...
MedMol S82344-1mg 99% ¥230.00元 10 - - - EA 加入購物車
MedMol S82344-5mg 99% ¥590.00元 6 - - - EA 加入購物車
MedMol S82344-10mg 99% ¥1050.00元 6 - - - EA 加入購物車
MedMol S82344-25mg 99% ¥1820.00元 6 - - - EA 加入購物車
大包裝詢價(jià)

提交您的電話號(hào)碼并同意《個(gè)人信息授權(quán)與保護(hù)申明》,到貨后將短信提示。
提交

產(chǎn)品介紹

參考文獻(xiàn)

質(zhì)檢證書(COA)

摩爾濃度計(jì)算器

相關(guān)產(chǎn)品

  • 提示:詳情請下載說明書。
  • 產(chǎn)品描述: MK-1064 is a selective and orally active OX2R antagonist (Ki: 0.5 nM, IC50: 18 nM). MK-1064 promotes sleep in vivo. MK-1064 can be used in the research of insomnia
  • 靶點(diǎn): OX2 Receptor:18 nM (IC50);OX1 Receptor:1789 nM (IC50);OX2 Receptor:0.5 nM (Ki);OX1 Receptor;1584 nM (Ki);OXReceptor
  • 體內(nèi)研究:
    MK-1064 (30?mg/kg, oral administration) promotes sleep in rodents selectively through OX2R in Wild-type mice. MK-1064 (30?mg/kg, oral administration, 5 days) reverses the struggle behavior induced by CNO pre-treatment in rats. MK-1064 (1-5 mg/kg, intravenous injection/oral administration) shows moderate oral bioavailability and clearance in rat, dog, and rhesus monkey. Animal Model: Wild-type and OX2R knockout mice Dosage: 30 mg/kg Administration: Oral administration Result: Displayed active wake reduction accompanied by significant increases in SWS (slow-wave sleep) and REM (rapid eye movement) at time points up to 3.5?hours following treatment. Animal Model: Rat, dog, and rhesus monkey (Pharmacokinetics assay) Dosage: 1, 2, 3, 5 mg/kg Administration: Oral administration (P.O.), intravenous injection (I.V.) Result: Pharmacokinetics profile of MK-1064.
  • 參考文獻(xiàn):
    1. Roecker AJ et al. Discovery of 5''-chloro-N-[(5,6-dimethoxypyridin-2-yl)methyl]-2,2':5',3''-terpyridine-3'-carboxamide (MK-1064): a selective orexin 2 receptor antagonist (2-SORA) for the treatment of insomnia. ChemMedChem. 2014 Feb;9(2):311-22. 2. Gotter AL et al. Orexin 2 Receptor Antagonism is Sufficient to Promote NREM and REM Sleep from Mouse to Man. Sci Rep. 2016 Jun 3;6:27147. 3. Laura A Grafe, et al. Orexin 2 receptor regulation of the hypothalamic-pituitary-adrenal (HPA) response to acute and repeated stress. Neuroscience. 2017 Apr 21;348:313-323.
  • 溶解性: soluble  in  DMSO
  • 保存條件: -20℃
  • 配置溶液濃度參考:
    1mg 5mg 10mg
    1 mM 2.165 ml 10.825 ml 21.65 ml
    5 mM 0.433 ml 2.165 ml 4.33 ml
    10 mM 0.216 ml 1.082 ml 2.165 ml
    50 mM 0.043 ml 0.216 ml 0.433 ml
  • 注意:部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權(quán)威性,僅供客戶參考交流研究之用。
  • 提示:詳情請下載說明書。
  • 產(chǎn)品描述: MK-1064 is a selective and orally active OX2R antagonist (Ki: 0.5 nM, IC50: 18 nM). MK-1064 promotes sleep in vivo. MK-1064 can be used in the research of insomnia
  • 靶點(diǎn): OX2 Receptor:18 nM (IC50);OX1 Receptor:1789 nM (IC50);OX2 Receptor:0.5 nM (Ki);OX1 Receptor;1584 nM (Ki);OXReceptor
  • 體內(nèi)研究:
    MK-1064 (30?mg/kg, oral administration) promotes sleep in rodents selectively through OX2R in Wild-type mice. MK-1064 (30?mg/kg, oral administration, 5 days) reverses the struggle behavior induced by CNO pre-treatment in rats. MK-1064 (1-5 mg/kg, intravenous injection/oral administration) shows moderate oral bioavailability and clearance in rat, dog, and rhesus monkey. Animal Model: Wild-type and OX2R knockout mice Dosage: 30 mg/kg Administration: Oral administration Result: Displayed active wake reduction accompanied by significant increases in SWS (slow-wave sleep) and REM (rapid eye movement) at time points up to 3.5?hours following treatment. Animal Model: Rat, dog, and rhesus monkey (Pharmacokinetics assay) Dosage: 1, 2, 3, 5 mg/kg Administration: Oral administration (P.O.), intravenous injection (I.V.) Result: Pharmacokinetics profile of MK-1064.
  • 參考文獻(xiàn):
    1. Roecker AJ et al. Discovery of 5''-chloro-N-[(5,6-dimethoxypyridin-2-yl)methyl]-2,2':5',3''-terpyridine-3'-carboxamide (MK-1064): a selective orexin 2 receptor antagonist (2-SORA) for the treatment of insomnia. ChemMedChem. 2014 Feb;9(2):311-22. 2. Gotter AL et al. Orexin 2 Receptor Antagonism is Sufficient to Promote NREM and REM Sleep from Mouse to Man. Sci Rep. 2016 Jun 3;6:27147. 3. Laura A Grafe, et al. Orexin 2 receptor regulation of the hypothalamic-pituitary-adrenal (HPA) response to acute and repeated stress. Neuroscience. 2017 Apr 21;348:313-323.
  • 溶解性: soluble  in  DMSO
  • 保存條件: -20℃
  • 配置溶液濃度參考:
    1mg 5mg 10mg
    1 mM 2.165 ml 10.825 ml 21.65 ml
    5 mM 0.433 ml 2.165 ml 4.33 ml
    10 mM 0.216 ml 1.082 ml 2.165 ml
    50 mM 0.043 ml 0.216 ml 0.433 ml
  • 注意:部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權(quán)威性,僅供客戶參考交流研究之用。
輸入產(chǎn)品批號(hào):

本計(jì)算器可幫助您計(jì)算出特定溶液中溶質(zhì)的質(zhì)量、溶液濃度和體積之間的關(guān)系,公式為:


質(zhì)量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)


  • =
    *
    *


源葉所有產(chǎn)品僅用作科學(xué)研究,銷售產(chǎn)品行為均適用于我司網(wǎng)上所列通用銷售條款。
点击收缩